These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6683010)

  • 1. Hyperglucagonemia following cisplatin treatment.
    Goldstein RS; Mayor GH; Gingerich RL; Hook JB; Robinson B; Bond JT
    Toxicol Appl Pharmacol; 1983 Apr; 68(2):250-9. PubMed ID: 6683010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function.
    Goldstein RS; Mayor GH; Gingerich RL; Hook JB; Rosenbaum RW; Bond JT
    Toxicol Appl Pharmacol; 1983 Jul; 69(3):432-41. PubMed ID: 6349015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration.
    Levi FA; Hrushesky WJ; Halberg F; Langevin TR; Haus E; Kennedy BJ
    Eur J Cancer Clin Oncol; 1982 May; 18(5):471-7. PubMed ID: 6889525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of metallothionein in renal toxicity of cisplatinum.
    Satoh M; Aoki Y; Tohyama C
    Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
    Levine BS; Henry MC; Port CD; Richter WR; Urbanek MA
    J Natl Cancer Inst; 1981 Jul; 67(1):201-6. PubMed ID: 6942191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and characterization of hyperglucagonemia in the uremic rat.
    Emmanouel DS; Jaspan JB; Kuku SF; Rubenstein AH; Katz AI; Huen AH
    J Clin Invest; 1976 Nov; 58(5):1266-72. PubMed ID: 993345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats.
    Dillioglugil MO; Maral Kir H; Gulkac MD; Ozon Kanli A; Ozdogan HK; Acar O; Dillioglugil O
    Urol Int; 2005; 75(4):340-4. PubMed ID: 16327303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
    Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
    Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose intolerance following cis-platinum treatment in rats.
    Goldstein RS; Mayor GH; Rosenbaum RW; Hook JB; Santiago JV; Bond JT
    Toxicology; 1982; 24(3-4):273-80. PubMed ID: 6765498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
    Satoh M; Naganuma A; Imura N
    Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of nitrogen from organs in rats induced by exogenous glucagon.
    Almdal TP; Vilstrup H
    Endocrinology; 1988 Nov; 123(5):2182-6. PubMed ID: 3049048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital.
    Diwan BA; Anderson LM; Ward JM; Henneman JR; Rice JM
    Toxicol Appl Pharmacol; 1995 May; 132(1):115-21. PubMed ID: 7747274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.
    Meek TH; Dorfman MD; Matsen ME; Fischer JD; Cubelo A; Kumar MR; Taborsky GJ; Morton GJ
    Diabetes; 2015 Jul; 64(7):2376-87. PubMed ID: 25633417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of cisplatin and N-methyliminodiacetato-(1,2-diaminocyclohexane)-platinum(II) on renal function and gentamicin excretion in rats.
    Engineer MS; Ho DH; Khokhar AR; Newman RA; Bulger RE
    Toxicology; 1987 Dec; 47(3):307-15. PubMed ID: 3424386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
    Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
    Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations.
    Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
    Ren Fail; 1995 Sep; 17(5):539-50. PubMed ID: 8570866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.